Search Legislation

Advanced Search

Commission Regulation (EC) No 1234/2008Show full title

Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

Help about what version

What Version

More Resources

Revised version PDFs

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes to legislation:

There are outstanding changes not yet made to Commission Regulation (EC) No 1234/2008. Those changes will be listed when you open the content using the Table of Contents below. Any changes that have already been made to the legislation appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.

View outstanding changes

Changes and effects yet to be applied to :

  1. Introductory Text

  2. CHAPTER I GENERAL PROVISIONS

    1. Article 1.Subject matter and scope

    2. Article 2.Definitions

    3. Article 3.Classification of variations

    4. Article 4. Guidelines

    5. Article 5.Recommendation on unforeseen variations

    6. Article 6.Variations leading to the revision of product information

    7. Article 7. Grouping of variations

  3. CHAPTER II VARIATIONS TO MARKETING AUTHORISATIONS GRANTED IN ACCORDANCE WITH DIRECTIVE 87/22/EEC, CHAPTER 4 OF DIRECTIVE 2001/82/EC OR CHAPTER 4 OF DIRECTIVE 2001/83/EC

    1. Article 8.Notification procedure for minor variations of type IA

    2. Article 9.Notification procedure for minor variations of type IB

    3. Article 10.‘Prior Approval’ procedure for major variations of type II

    4. Article 11.Measures to close the procedures of Articles 8 to 10

    5. Article 12.Human influenza vaccines

    6. Article 13.Coordination group and arbitration

  4. CHAPTER IIa VARIATIONS TO PURELY NATIONAL MARKETING AUTHORISATIONS

    1. Article 13a. Notification procedure for minor variations of type IA

    2. Article 13b. Notification procedure for minor variations of type IB

    3. Article 13c.‘Prior Approval’ procedure for major variations of type II

    4. Article 13d. Grouping of variations to purely national marketing authorisations

    5. Article 13e. Measures to close the procedures of Articles 13a to 13c

    6. Article 13f. Human influenza vaccines

  5. CHAPTER III VARIATIONS TO CENTRALISED MARKETING AUTHORISATIONS

    1. Article 14.Notification procedure for minor variations of type IA

    2. Article 15.Notification procedure for minor variations of type IB

    3. Article 16.‘Prior Approval’ procedure for major variations of type II

    4. Article 17. Measures to close the procedures of Articles 14 to 16

    5. Article 18.Human influenza vaccines

  6. CHAPTER IV

    1. SECTION 1 Special procedures

      1. Article 19.Extensions of marketing authorisations

      2. Article 20.Worksharing procedure

      3. Article 21.Pandemic situation with respect to human influenza

      4. Article 22.Urgent safety restrictions

    2. SECTION 2 Amendments to the decision granting the marketing authorisation and implementation

      1. Article 23.Amendments to the decision granting the marketing authorisation

      2. Article 23a.The statement indicating compliance with the agreed completed paediatric investigation...

      3. Article 24. Implementation of variations

      4. Article 24a. Application of national provisions on variations to purely national marketing authorisations

  7. CHAPTER V FINAL PROVISIONS

    1. Article 25.Continuous monitoring

    2. Article 26.Review

    3. Article 27.Repeal and transitional provision

    4. Article 28.Entry into force

  8. Signature

    1. ANNEX I

      Extensions of marketing authorisations

      1. 1. Changes to the active substance(s):

      2. 2. Changes to strength, pharmaceutical form and route of administration:

      3. 3. Other changes specific to veterinary medicinal products to be administered...

    2. ANNEX II

      Classification of variations

      1. 1. The following variations shall be classified as minor variations of...

      2. 2. The following variations shall be classified as major variations of...

    3. ANNEX III

      Cases for grouping variations referred to in Article 7(2)(b) and Article 13d(2)(b)

      1. 1. One of the variations in the group is an extension...

      2. 2. One of the variations in the group is a major...

      3. 3. One of the variations in the group is a minor...

      4. 4. All variations in the group relate solely to changes of...

      5. 5. All variations in the group are changes to an Active...

      6. 6. All variations in the group relate to a project intended...

      7. 7. All variations in the group are changes affecting the quality...

      8. 8. All variations in the group are changes to the pharmacovigilance...

      9. 9. All variations in the group are consequential to a given...

      10. 10. All variations in the group relate to the implementation of...

      11. 11. All variations in the group are consequential to the assessment...

      12. 12. All variations in the group are consequential to a given...

      13. 13. All variations in the group are consequential to a specific...

      14. 14. All variations in the group are consequential to a specific...

    4. ANNEX IV

      Elements to be submitted

      1. 1. A list of all the marketing authorisations affected by the...

      2. 2. A description of all the variations submitted, including:

      3. 3. All necessary documents as listed in the guidelines referred to...

      4. 4. Where a variation leads to or is the consequence of...

      5. 5. In the case of variations to centralised marketing authorisations, the...

      6. 6. In the case of variations to marketing authorisations granted by...

    5. ANNEX V

      1. PART 1

      2. PART 2

        1. 1. Variations concerning a change to or addition of a non-food...

        2. 2. Variations concerning the replacement or addition of a serotype, strain,...

        3. 3. Variations concerning the replacement of a strain for a veterinary...

    6. ANNEX VI

      List of Member States referred in Article 24a

      1. the Republic of Bulgaria, the Federal Republic of Germany.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources